Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
Author:
Publisher
Elsevier BV
Subject
Dermatology,Molecular Biology,Biochemistry
Reference41 articles.
1. Pathogenesis, classification and treatment of inflammatory myopathies;Zong;Nat. Rev. Rheumatol.,2011
2. Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies;Tansley;Curr. Rheumatol. Rep.,2014
3. Myositis autoantibodies;Casciola-Rosen;Curr. Opin. Rheumatol.,2012
4. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis;Betteridge;J. Intern. Med.,2016
5. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy;Satoh;Clin. Rev. Allergy Immunol.,2016
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis;Arthritis & Rheumatology;2023-07-19
2. Age distribution and prevalence in different age groups of four myositis‐specific autoantibodies, including anti‐ARS, anti‐MDA5, anti‐Mi‐2, and anti‐TIF1γ antibodies;The Journal of Dermatology;2023-03-08
3. Authors' reply to “a case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on the article by Mizumaki et al.”;The Journal of Dermatology;2023-01-26
4. Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study;Rheumatology;2022-10-17
5. A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1 ‐γ ELISA results: Comment on “Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody”;The Journal of Dermatology;2022-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3